NEW REPORT: Big Pharma Hikes Drug Prices in Midst of COVID-19 Crisis
Drug companies raised the price of nearly 250 drugs since COVID-19 arrived in U.S.; 75 percent of those were drugs linked to COVID-19.
Kaiser Health News: Drugmakers Tout COVID-19 Vaccines To Refurbish Their Public Image
J&J and the rest of the pharmaceutical industry have seized on the coronavirus crisis as a way to polish an image tarnished by unaffordable medicine, patent lawsuits and an addiction epidemic.
AXIOS: Drugmaker tripled the price of a pill as it pursued coronavirus use
"The price hike coincides with the company's push to get its drug to more patients — specifically those diagnosed with COVID-19."
Statement: Public-Private Partnership to Drive COVID-19 Research Overlooks Drug Prices
The federal government will be the single largest investor and the largest purchaser of an upcoming COVID-19 vaccine or treatment.
A Letter to Insulin Manufacturers
We are writing to implore you to take urgent action to improve access to insulin products in light of the current COVID-19 pandemic.
BY THE NUMBERS: New Analysis Finds Over 500 Drug Price Hikes In First Week of January
New report shows an average increase of 5.6%
Reaction to White House Blog Post on H.R. 3
Council of Economic Advisers analysis puts politics over patients.
STAT OP-ED: Letting academic medical centers make CAR-T drugs would save billions
High prices not only pose a challenge to patient access, but they also raise a fundamental question: Are we creating these therapies the wrong way?
